Why Abzena?
Our focused approach.
Taking the decision to work with a CDMO partner is challenging, and amongst the most crucial early decisions you will make on your molecule’s development. Abzena are ready to work together with you to de-risk and streamline the development and manufacture of your novel treatments so that you can rapidly bridge from discovery through commercial launch.
We offer a uniquely collaborative, personalized, and transparent partnership differentiated by our values and insights gained from over 20 years of experience and multiple decades of scientific knowledge.
We offer best-in-class biologics, bioconjugates and ADC CDMO + CRO services along with a highly detailed and personalized experience. Contact us today to find out more about our expanding ADC capabilities.
From biologics design to ADC developability, through to commercial manufacturing, Abzena offer integrated contract research, development, and manufacturing services for many of the leading pharma and biotech customers. Our scientific experts at our locations in Cambridge UK, Bristol and San Diego USA have experience working with hundreds of molecules across all stages of the drug development process.
Enhance your ADC development with our ThioBridge® conjugation platform technology.
Abzena has over 20 years of expertise in identifying and mapping the appropriate design space for the development of your complex antibody-drug conjugates (ADCs). Through our developability assessments, we identify and de-risk your clinical candidates for development, ensuring that your timescales are met.